Farha P - Search Results

1

Correlation Between Cephalometric Values and Soft Tissue Profile in Class I and Class II Adult Patients based on Vertical Patterns.

Farha P, Arqub SA, Ghoussoub MS. Farha P, et al. Turk J Orthod. 2024 Mar 28;37(1):36-43. doi: 10.4274/TurkJOrthod.2023.2022.20. Turk J Orthod. 2024. PMID: 38556951 Free PMC article.

2

Orthodontic Localization of Impacted Canines: Review of the Cutting-edge Evidence in Diagnosis and Treatment Planning Based on 3D CBCT Images.

Farha P, Nguyen M, Karanth D, Dolce C, Arqub SA. Farha P, et al. Turk J Orthod. 2023 Dec 29;36(4):261-269. doi: 10.4274/TurkJOrthod.2023.2022.131. Turk J Orthod. 2023. PMID: 38164014 Free PMC article.

3

Assessment of the efficacy of various maxillary molar intrusion therapies: a systematic review.

Abu Arqub S, Al-Moghrabi D, Iverson MG, Farha P, Alsalman HA, Uribe F. Abu Arqub S, et al. Among authors: farha p. Prog Orthod. 2023 Nov 13;24(1):37. doi: 10.1186/s40510-023-00490-3. Prog Orthod. 2023. PMID: 37953383 Free PMC article. Review.

4

An exploration of facilitators and barriers to patient navigator core functions with breast cancer patients: Implications for the development of a human-centered mHealth app.

Carr AL, Vinod N, Farha P, Lu T, Farha MJ, Graves KD. Carr AL, et al. Among authors: farha p. PEC Innov. 2023 Oct 4;3:100226. doi: 10.1016/j.pecinn.2023.100226. eCollection 2023 Dec 15. PEC Innov. 2023. PMID: 37859864 Free PMC article.

5

Imido-hydrido complexes of Mo(IV): catalysis and mechanistic aspects of hydroboration reactions.

Khalimon AY, Farha PM, Nikonov GI. Khalimon AY, et al. Among authors: farha pm. Dalton Trans. 2015 Nov 21;44(43):18945-56. doi: 10.1039/c5dt02945g. Dalton Trans. 2015. PMID: 26469856

6

Catalytic hydroboration by an imido-hydrido complex of Mo(IV).

Khalimon AY, Farha P, Kuzmina LG, Nikonov GI. Khalimon AY, et al. Among authors: farha p. Chem Commun (Camb). 2012 Jan 11;48(3):455-7. doi: 10.1039/c1cc14508h. Epub 2011 Nov 11. Chem Commun (Camb). 2012. PMID: 22076679

7

Use of carcinoembryonic antigen in small cell lung cancer. Prognostic value and relation to the clinical course 1.

Laberge F, Fritsche HA, Umsawasdi T, Carr DT, Welch S, Murphy WK, Chiuten DF, Dhingra HM, Farha P, Spitzer G, et al. Laberge F, et al. Among authors: farha p. Cancer. 1987 Jun 15;59(12):2047-52. doi: 10.1002/1097-0142(19870615)59:12<2047::aid-cncr2820591214>3.0.co;2-9. Cancer. 1987. PMID: 3032400

8

I.v. melphalan in carcinoma of the lung: effect of cyclophosphamide priming on hematopoietic toxicity.

Spitzer G, Valdivieso M, Farha P, Murphy WK, Dhingra HM, Chiuten D, Umsawasdi T, Holoye P. Spitzer G, et al. Among authors: farha p. Cancer Treat Rep. 1986 Apr;70(4):449-53. Cancer Treat Rep. 1986. PMID: 3698037

9

High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma.

Spitzer G, Farha P, Valdivieso M, Dicke K, Zander A, Vellekoop L, Murphy WK, Dhingra HM, Umsawasdi T, Chiuten D, et al. Spitzer G, et al. Among authors: farha p. J Clin Oncol. 1986 Jan;4(1):4-13. doi: 10.1200/JCO.1986.4.1.4. J Clin Oncol. 1986. PMID: 3510281 Clinical Trial.

10

Esophageal complications from combined chemoradiotherapy (cyclophosphamide + Adriamycin + cisplatin + XRT) in the treatment of non-small cell lung cancer.

Umsawasdi T, Valdivieso M, Barkley HT Jr, Booser DJ, Chiuten DF, Murphy WK, Dhingra HM, Dixon CL, Farha P, Spitzer G, et al. Umsawasdi T, et al. Among authors: farha p. Int J Radiat Oncol Biol Phys. 1985 Mar;11(3):511-9. doi: 10.1016/0360-3016(85)90182-8. Int J Radiat Oncol Biol Phys. 1985. PMID: 3838297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page